 | • レポートコード：QYR2104Z1453 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、結腸直腸がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、免疫療法）、用途別市場規模（早期結腸直腸がん、中期結腸直腸がん、後期結腸直腸がん）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・結腸直腸がんの市場動向 ・企業の競争状況、市場シェア ・結腸直腸がんの種類別市場規模（化学療法、標的療法、免疫療法） ・結腸直腸がんの用途別市場規模（早期結腸直腸がん、中期結腸直腸がん、後期結腸直腸がん） ・結腸直腸がんの北米市場規模2016-2027（アメリカ、カナダ） ・結腸直腸がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・結腸直腸がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・結腸直腸がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・結腸直腸がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Debiopharm、Merck Kgaa、Vaccinogen、Aeterna Zentaris、Keryx、Spectrum Pharmaceuticals、Mologen、Amgen、Bayer Healthcare） ・結論 |
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).
The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of weight, nausea, vomiting, fatigue, lump in back passage, and iron deficiency in aged person.
Market Analysis and Insights: Global Colorectal Cancer Market
The global Colorectal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colorectal Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colorectal Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colorectal Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colorectal Cancer market.
Global Colorectal Cancer Scope and Market Size
Colorectal Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Targeted therapy
Immunotherapy
Segment by Application
Early Colorectal Cancer
Midterm Colorectal Cancer
Late Colorectal Cancer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Debiopharm
Merck Kgaa
Vaccinogen
Aeterna Zentaris
Keryx
Spectrum Pharmaceuticals
Mologen
Amgen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Targeted therapy
1.2.4 Immunotherapy
1.3 Market by Application
1.3.1 Global Colorectal Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Early Colorectal Cancer
1.3.3 Midterm Colorectal Cancer
1.3.4 Late Colorectal Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Market Perspective (2016-2027)
2.2 Colorectal Cancer Growth Trends by Regions
2.2.1 Colorectal Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Colorectal Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Colorectal Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Colorectal Cancer Industry Dynamic
2.3.1 Colorectal Cancer Market Trends
2.3.2 Colorectal Cancer Market Drivers
2.3.3 Colorectal Cancer Market Challenges
2.3.4 Colorectal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Players by Revenue
3.1.1 Global Top Colorectal Cancer Players by Revenue (2016-2021)
3.1.2 Global Colorectal Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Colorectal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Revenue
3.4 Global Colorectal Cancer Market Concentration Ratio
3.4.1 Global Colorectal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Revenue in 2020
3.5 Colorectal Cancer Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Breakdown Data by Type
4.1 Global Colorectal Cancer Historic Market Size by Type (2016-2021)
4.2 Global Colorectal Cancer Forecasted Market Size by Type (2022-2027)
5 Colorectal Cancer Breakdown Data by Application
5.1 Global Colorectal Cancer Historic Market Size by Application (2016-2021)
5.2 Global Colorectal Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Colorectal Cancer Market Size (2016-2027)
6.2 North America Colorectal Cancer Market Size by Type
6.2.1 North America Colorectal Cancer Market Size by Type (2016-2021)
6.2.2 North America Colorectal Cancer Market Size by Type (2022-2027)
6.2.3 North America Colorectal Cancer Market Size by Type (2016-2027)
6.3 North America Colorectal Cancer Market Size by Application
6.3.1 North America Colorectal Cancer Market Size by Application (2016-2021)
6.3.2 North America Colorectal Cancer Market Size by Application (2022-2027)
6.3.3 North America Colorectal Cancer Market Size by Application (2016-2027)
6.4 North America Colorectal Cancer Market Size by Country
6.4.1 North America Colorectal Cancer Market Size by Country (2016-2021)
6.4.2 North America Colorectal Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Colorectal Cancer Market Size (2016-2027)
7.2 Europe Colorectal Cancer Market Size by Type
7.2.1 Europe Colorectal Cancer Market Size by Type (2016-2021)
7.2.2 Europe Colorectal Cancer Market Size by Type (2022-2027)
7.2.3 Europe Colorectal Cancer Market Size by Type (2016-2027)
7.3 Europe Colorectal Cancer Market Size by Application
7.3.1 Europe Colorectal Cancer Market Size by Application (2016-2021)
7.3.2 Europe Colorectal Cancer Market Size by Application (2022-2027)
7.3.3 Europe Colorectal Cancer Market Size by Application (2016-2027)
7.4 Europe Colorectal Cancer Market Size by Country
7.4.1 Europe Colorectal Cancer Market Size by Country (2016-2021)
7.4.2 Europe Colorectal Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Market Size (2016-2027)
8.2 Asia-Pacific Colorectal Cancer Market Size by Type
8.2.1 Asia-Pacific Colorectal Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Colorectal Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Colorectal Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Colorectal Cancer Market Size by Application
8.3.1 Asia-Pacific Colorectal Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Colorectal Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Colorectal Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Colorectal Cancer Market Size by Region
8.4.1 Asia-Pacific Colorectal Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Colorectal Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Market Size (2016-2027)
9.2 Latin America Colorectal Cancer Market Size by Type
9.2.1 Latin America Colorectal Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Colorectal Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Colorectal Cancer Market Size by Type (2016-2027)
9.3 Latin America Colorectal Cancer Market Size by Application
9.3.1 Latin America Colorectal Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Colorectal Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Colorectal Cancer Market Size by Application (2016-2027)
9.4 Latin America Colorectal Cancer Market Size by Country
9.4.1 Latin America Colorectal Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Colorectal Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Market Size (2016-2027)
10.2 Middle East & Africa Colorectal Cancer Market Size by Type
10.2.1 Middle East & Africa Colorectal Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Colorectal Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Colorectal Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Colorectal Cancer Market Size by Application
10.3.1 Middle East & Africa Colorectal Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Colorectal Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Colorectal Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Colorectal Cancer Market Size by Country
10.4.1 Middle East & Africa Colorectal Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Colorectal Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Colorectal Cancer Introduction
11.1.4 Roche Revenue in Colorectal Cancer Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Debiopharm
11.2.1 Debiopharm Company Details
11.2.2 Debiopharm Business Overview
11.2.3 Debiopharm Colorectal Cancer Introduction
11.2.4 Debiopharm Revenue in Colorectal Cancer Business (2016-2021)
11.2.5 Debiopharm Recent Development
11.3 Merck Kgaa
11.3.1 Merck Kgaa Company Details
11.3.2 Merck Kgaa Business Overview
11.3.3 Merck Kgaa Colorectal Cancer Introduction
11.3.4 Merck Kgaa Revenue in Colorectal Cancer Business (2016-2021)
11.3.5 Merck Kgaa Recent Development
11.4 Vaccinogen
11.4.1 Vaccinogen Company Details
11.4.2 Vaccinogen Business Overview
11.4.3 Vaccinogen Colorectal Cancer Introduction
11.4.4 Vaccinogen Revenue in Colorectal Cancer Business (2016-2021)
11.4.5 Vaccinogen Recent Development
11.5 Aeterna Zentaris
11.5.1 Aeterna Zentaris Company Details
11.5.2 Aeterna Zentaris Business Overview
11.5.3 Aeterna Zentaris Colorectal Cancer Introduction
11.5.4 Aeterna Zentaris Revenue in Colorectal Cancer Business (2016-2021)
11.5.5 Aeterna Zentaris Recent Development
11.6 Keryx
11.6.1 Keryx Company Details
11.6.2 Keryx Business Overview
11.6.3 Keryx Colorectal Cancer Introduction
11.6.4 Keryx Revenue in Colorectal Cancer Business (2016-2021)
11.6.5 Keryx Recent Development
11.7 Spectrum Pharmaceuticals
11.7.1 Spectrum Pharmaceuticals Company Details
11.7.2 Spectrum Pharmaceuticals Business Overview
11.7.3 Spectrum Pharmaceuticals Colorectal Cancer Introduction
11.7.4 Spectrum Pharmaceuticals Revenue in Colorectal Cancer Business (2016-2021)
11.7.5 Spectrum Pharmaceuticals Recent Development
11.8 Mologen
11.8.1 Mologen Company Details
11.8.2 Mologen Business Overview
11.8.3 Mologen Colorectal Cancer Introduction
11.8.4 Mologen Revenue in Colorectal Cancer Business (2016-2021)
11.8.5 Mologen Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Colorectal Cancer Introduction
11.9.4 Amgen Revenue in Colorectal Cancer Business (2016-2021)
11.9.5 Amgen Recent Development
11.10 Bayer Healthcare
11.10.1 Bayer Healthcare Company Details
11.10.2 Bayer Healthcare Business Overview
11.10.3 Bayer Healthcare Colorectal Cancer Introduction
11.10.4 Bayer Healthcare Revenue in Colorectal Cancer Business (2016-2021)
11.10.5 Bayer Healthcare Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Colorectal Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted therapy
Table 4. Key Players of Immunotherapy
Table 5. Global Colorectal Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Colorectal Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Colorectal Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Colorectal Cancer Market Share by Regions (2016-2021)
Table 9. Global Colorectal Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Colorectal Cancer Market Share by Regions (2022-2027)
Table 11. Colorectal Cancer Market Trends
Table 12. Colorectal Cancer Market Drivers
Table 13. Colorectal Cancer Market Challenges
Table 14. Colorectal Cancer Market Restraints
Table 15. Global Colorectal Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Colorectal Cancer Market Share by Players (2016-2021)
Table 17. Global Top Colorectal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer as of 2020)
Table 18. Ranking of Global Top Colorectal Cancer Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Colorectal Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Colorectal Cancer Product Solution and Service
Table 22. Date of Enter into Colorectal Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Colorectal Cancer Revenue Market Share by Type (2016-2021)
Table 26. Global Colorectal Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Colorectal Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Colorectal Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Colorectal Cancer Revenue Market Share by Application (2016-2021)
Table 30. Global Colorectal Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Colorectal Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Colorectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Colorectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Colorectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Colorectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Colorectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Colorectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Colorectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Colorectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Colorectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Colorectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Colorectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Colorectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Colorectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Colorectal Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Colorectal Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Colorectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Colorectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Colorectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Colorectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Colorectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Colorectal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Colorectal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Colorectal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Colorectal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Colorectal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Colorectal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Colorectal Cancer Product
Table 65. Roche Revenue in Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Debiopharm Company Details
Table 68. Debiopharm Business Overview
Table 69. Debiopharm Colorectal Cancer Product
Table 70. Debiopharm Revenue in Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 71. Debiopharm Recent Development
Table 72. Merck Kgaa Company Details
Table 73. Merck Kgaa Business Overview
Table 74. Merck Kgaa Colorectal Cancer Product
Table 75. Merck Kgaa Revenue in Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 76. Merck Kgaa Recent Development
Table 77. Vaccinogen Company Details
Table 78. Vaccinogen Business Overview
Table 79. Vaccinogen Colorectal Cancer Product
Table 80. Vaccinogen Revenue in Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 81. Vaccinogen Recent Development
Table 82. Aeterna Zentaris Company Details
Table 83. Aeterna Zentaris Business Overview
Table 84. Aeterna Zentaris Colorectal Cancer Product
Table 85. Aeterna Zentaris Revenue in Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 86. Aeterna Zentaris Recent Development
Table 87. Keryx Company Details
Table 88. Keryx Business Overview
Table 89. Keryx Colorectal Cancer Product
Table 90. Keryx Revenue in Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 91. Keryx Recent Development
Table 92. Spectrum Pharmaceuticals Company Details
Table 93. Spectrum Pharmaceuticals Business Overview
Table 94. Spectrum Pharmaceuticals Colorectal Cancer Product
Table 95. Spectrum Pharmaceuticals Revenue in Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 96. Spectrum Pharmaceuticals Recent Development
Table 97. Mologen Company Details
Table 98. Mologen Business Overview
Table 99. Mologen Revenue in Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 100. Mologen Recent Development
Table 101. Amgen Company Details
Table 102. Amgen Business Overview
Table 103. Amgen Colorectal Cancer Product
Table 104. Amgen Revenue in Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 105. Amgen Recent Development
Table 106. Bayer Healthcare Company Details
Table 107. Bayer Healthcare Business Overview
Table 108. Bayer Healthcare Colorectal Cancer Product
Table 109. Bayer Healthcare Revenue in Colorectal Cancer Business (2016-2021) & (US$ Million)
Table 110. Bayer Healthcare Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Targeted therapy Features
Figure 4. Immunotherapy Features
Figure 5. Global Colorectal Cancer Market Share by Application: 2020 VS 2027
Figure 6. Early Colorectal Cancer Case Studies
Figure 7. Midterm Colorectal Cancer Case Studies
Figure 8. Late Colorectal Cancer Case Studies
Figure 9. Colorectal Cancer Report Years Considered
Figure 10. Global Colorectal Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Colorectal Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Colorectal Cancer Market Share by Regions: 2020 VS 2027
Figure 13. Global Colorectal Cancer Market Share by Regions (2022-2027)
Figure 14. Global Colorectal Cancer Market Share by Players in 2020
Figure 15. Global Top Colorectal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Colorectal Cancer Revenue in 2020
Figure 17. Global Colorectal Cancer Revenue Market Share by Type (2016-2021)
Figure 18. Global Colorectal Cancer Revenue Market Share by Type (2022-2027)
Figure 19. North America Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Colorectal Cancer Market Share by Type (2016-2027)
Figure 21. North America Colorectal Cancer Market Share by Application (2016-2027)
Figure 22. North America Colorectal Cancer Market Share by Country (2016-2027)
Figure 23. United States Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Colorectal Cancer Market Share by Type (2016-2027)
Figure 27. Europe Colorectal Cancer Market Share by Application (2016-2027)
Figure 28. Europe Colorectal Cancer Market Share by Country (2016-2027)
Figure 29. Germany Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Colorectal Cancer Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Colorectal Cancer Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Colorectal Cancer Market Share by Region (2016-2027)
Figure 39. China Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Colorectal Cancer Market Share by Type (2016-2027)
Figure 47. Latin America Colorectal Cancer Market Share by Application (2016-2027)
Figure 48. Latin America Colorectal Cancer Market Share by Country (2016-2027)
Figure 49. Mexico Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Colorectal Cancer Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Colorectal Cancer Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Colorectal Cancer Market Share by Country (2016-2027)
Figure 55. Turkey Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Colorectal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Roche Revenue Growth Rate in Colorectal Cancer Business (2016-2021)
Figure 59. Debiopharm Revenue Growth Rate in Colorectal Cancer Business (2016-2021)
Figure 60. Merck Kgaa Revenue Growth Rate in Colorectal Cancer Business (2016-2021)
Figure 61. Vaccinogen Revenue Growth Rate in Colorectal Cancer Business (2016-2021)
Figure 62. Aeterna Zentaris Revenue Growth Rate in Colorectal Cancer Business (2016-2021)
Figure 63. Keryx Revenue Growth Rate in Colorectal Cancer Business (2016-2021)
Figure 64. Spectrum Pharmaceuticals Revenue Growth Rate in Colorectal Cancer Business (2016-2021)
Figure 65. Mologen Revenue Growth Rate in Colorectal Cancer Business (2016-2021)
Figure 66. Amgen Revenue Growth Rate in Colorectal Cancer Business (2016-2021)
Figure 67. Bayer Healthcare Revenue Growth Rate in Colorectal Cancer Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の結腸直腸がん分子診断市場規模・現状・予測（2021年-2027年） Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor to personalized medicine…- 世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の転移性結腸直腸癌手術市場規模・現状・予測（2021年-2027年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- 世界の肛門・大腸がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anal and Colorectal Cancer Market The global Anal and Colorectal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …